Chronic obstructive pulmonary disease and sleep apnea syndrome
- PMID: 1470805
Chronic obstructive pulmonary disease and sleep apnea syndrome
Abstract
The term "overlap syndrome" was introduced by Flenley to describe the association of sleep apnea syndrome (SAS) with chronic obstructive pulmonary disease (COPD). Epidemiologic data on the prevalence of the overlap syndrome are not available, but the frequency of an associated COPD in SAS patients has been emphasized in almost all the studies analyzing the development of respiratory insufficiency in SAS patients. In a large series (n = 264) of unselected SAS patients who had undergone detailed pulmonary function tests, we observed an obstructive ventilatory defect (FEV1/VC < 60%) in 30 of 264 patients (11%). These patients had lower daytime PaO2 and higher PaCO2 than the other patients and they had higher resting and exercising pulmonary artery mean pressure (right heart catheterization was performed in 215 of 264 patients). We conclude that the risk of developing respiratory insufficiency and cor pulmonale is higher in overlap patients.
Similar articles
-
[Incidence of chronic obstructive respiratory tract disease in patients with obstructive sleep apnea].Pneumologie. 1996 Apr;50(4):286-9. Pneumologie. 1996. PMID: 8685203 German.
-
[Relationship between clinical symptoms and nocturnal oxygen desaturation in sleep apnea syndrome and chronic lung disease].Nihon Kyobu Shikkan Gakkai Zasshi. 1992 Apr;30(4):577-84. Nihon Kyobu Shikkan Gakkai Zasshi. 1992. PMID: 1405071 Japanese.
-
[Incidence of obstructive sleep apnea syndrome in combination with chronic obstructive respiratory tract disease].Pneumologie. 1993 Dec;47 Suppl 4:731-4. Pneumologie. 1993. PMID: 8153097 German.
-
[Sleep apnea and chronic obstructive respiratory tract disease (COPD): diagnostic and therapeutic consequences].Pneumologie. 1996 Apr;50(4):278-85. Pneumologie. 1996. PMID: 8685202 Review. German. No abstract available.
-
[Obstructive sleep apnea and hypertension. Diagnostic procedure--exclusion of risk factors--nCPAP treatment].Fortschr Med. 1998 Jun 10;116(16):24-7. Fortschr Med. 1998. PMID: 9674332 Review. German.
Cited by
-
Pathophysiology and clinical implications of pulmonary arterial enlargement in COPD.Int J Chron Obstruct Pulmon Dis. 2013;8:509-21. doi: 10.2147/COPD.S52204. Epub 2013 Oct 29. Int J Chron Obstruct Pulmon Dis. 2013. PMID: 24235822 Free PMC article. Review.
-
Sleep disruption as a predictor of quality of life among patients in the subpopulations and intermediate outcome measures in COPD study (SPIROMICS).Sleep. 2018 May 1;41(5):zsy044. doi: 10.1093/sleep/zsy044. Sleep. 2018. PMID: 29534240 Free PMC article.
-
New developments in the management of chronic obstructive pulmonary disease and the overlap syndrome.Curr Treat Options Neurol. 2011 Oct;13(5):488-95. doi: 10.1007/s11940-011-0136-7. Curr Treat Options Neurol. 2011. PMID: 21720742
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical